Skip to content
lifestyle.recentlegalnews.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Regenerative Medical Technology Group
RMTG More Than Quadruples Revenue and Gross Profit in Q2 2026 Versus Q2 2025, With Operating Income Surpassing $560,000
August 20, 2026
RMTG Provides Details for First-Ever Investor Call to Answer Shareholder Questions
August 19, 2026
RMTG Expands Cellgenic’s Cancún Laboratory Infrastructure with Two Additional ISO 7 Clean Rooms
August 18, 2026
RMTG to Hold First-Ever Investor Call to Discuss Second Quarter 2026 Results
August 5, 2026
RMTG Expands Cellgenic Operations Into Argentina, Establishing a Strategic Commercial Hub for Regenerative Medicine in Latin America
July 23, 2026
RMTG Subsidiary Cellgenic Commences Full-Scale Manufacturing at First-of-Its-Kind
March 26, 2026